RazaghianA, MoradiL, AllahverdiB, et al.Atopic March in a Case of Filkaggrin Gene Mutation. Pediatr Allergy Immunol Pulmonol; 2025.
2.
SandilandsA, SutherlandC, IrvineAD, et al.Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci, 2009; 122(Pt 9):1285–1294; doi: 10.1242/jcs.033969
3.
KashemSW, HaniffaM, KaplanDH. Antigen-Presenting cells in the skin. Annu Rev Immunol, 2017; 35:469–499; doi: 10.1146/annurev-immunol-051116-052215
4.
HoppRJ, SalazarP, PashaMA. Allergic food sensitization and disease manifestation in the fetus and infant: A perspective. Allergies, 2021; 1(2):115–122. https://doi.org/10.3390/allergies1020009
5.
SilverbergNB, SilverbergJI. Inside out or outside in: Does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis? Cutis, 2015; 96(6):359–361.
6.
BroughHA, SantosAF, MakinsonK, et al.Peanut protein in household dust is related to household peanut consumption and is biologically active. J Allergy Clin Immunol, 2013; 132(3):630–638; doi: 10.1016/j.jaci.2013.02.034
7.
HillDA, SpergelJM. Is eosinophilic esophagitis a member of the atopic march? Ann Allergy Asthma Immunol, 2018; 120(2):113–114; doi: 10.1016/j.anai.2017.10.003
8.
MikhailI, GraysonMH. Asthma and viral infections: An intricate relationship. Ann Allergy Asthma Immunol, 2019; 123(4):352–358; doi: 10.1016/j.anai.2019.06.020
9.
KottyanLC, ParameswaranS, WeirauchMT, et al.The genetic etiology of eosinophilic esophagitis. J Allergy Clin Immunol, 2020; 145(1):9–15; doi: 10.1016/j.jaci.2019.11.013
10.
MengJ, XiaoH, XuF, et al.Systemic barrier dysfunction in type 2 inflammation diseases: Perspective in the skin, airways, and gastrointestinal tract. Immunol Res, 2025; 73(1):60; doi: 10.1007/s12026-025-09606-9
11.
SpergelJM. Can we prevent allergies? Ann Allergy Asthma Immunol, 2022; 129(3):261–262; doi: 10.1016/j.anai.2022.06.004
12.
LinTL, FanYH, FanKS, et al.Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study. J Am Acad Dermatol, 2024; 91(3):466–473; doi: 10.1016/j.jaad.2024.05.029
